Development of Septoria villarsiae for biological control of Nymphoides peltata | W81EWF 21 SOI 0005

Opportunity Information: Apply for W81EWF 21 SOI 0005

The grant opportunity titled "Development of Septoria villarsiae for biological control of Nymphoides peltata" is a Department of Defense, U.S. Army Corps of Engineers research effort focused on evaluating a fungal pathogen, Septoria villarsiae, as a potential biological control tool for Nymphoides peltata (commonly known as yellow floating heart), an introduced aquatic plant that can form dense mats and disrupt waterways. The funding mechanism is a cooperative agreement, which typically means the agency expects to be actively involved during the project through coordination, technical input, or shared responsibilities rather than simply issuing funds and stepping back. The opportunity was posted December 9, 2020, with an original closing date of February 8, 2021. It anticipated a single award with a relatively small ceiling of $20,000, indicating a targeted, early-stage research or planning effort rather than a large multi-institution program.

The project is laid out as a sequence of objectives designed to move from basic laboratory development toward applied testing and, if the results justify it, eventual steps toward regulatory approval and real-world trials. The first objective, anticipated for Year 1, is to determine the optimal conditions for growth and culture of S. villarsiae. In practical terms, this is about learning how to reliably produce and maintain the fungus under controlled conditions, such as identifying the best media, temperature, light, humidity, and handling methods to generate consistent inoculum. This foundational work matters because biocontrol research depends on being able to reproduce results, compare treatments, and potentially scale up production for later testing.

The second objective spans anticipated Years 1 and 2 and focuses on host-range testing, which is one of the most important screening steps for any prospective biocontrol agent. The purpose is to assess whether S. villarsiae affects only the target plant (N. peltata) or whether it can also infect or damage other plant species present in the United States, including native plants and other introduced species. Host-range work generally involves exposing a carefully selected set of plants to the organism under controlled conditions and monitoring for infection, symptom development, and any measurable harm. This step is central to evaluating safety, because a biocontrol agent must show a high degree of specificity to avoid unintended impacts on non-target vegetation, particularly native or economically important species.

The third objective is scheduled for Year 2 and shifts attention to performance against the target weed across multiple introduced populations of N. peltata. This recognizes that invasive species can vary genetically and environmentally from place to place, and a biocontrol organism that works well on one population may be less effective on another. Testing across multiple populations helps determine whether the fungus produces consistent disease pressure and whether its effectiveness is robust across different source populations, which is important for judging how broadly useful it might be as a management tool.

The fourth objective, also anticipated for Year 2, is to determine the overall viability of S. villarsiae as a biocontrol agent and to outline next steps for regulatory approval and field tests. This is essentially a go/no-go decision point based on the accumulated evidence from culture work, host-range testing, and impact assessments. If the fungus appears effective and sufficiently host-specific, the project would then map out what additional studies, documentation, and approvals would be needed before it could be tested outside controlled settings. For biological control agents, regulatory pathways typically require clear evidence of specificity and an assessment of ecological risks, along with structured plans for contained trials and monitoring.

The fifth objective is presented as an optional extension for anticipated Years 3 through 5 and involves identifying field demonstration locations and conducting field trials to evaluate efficacy under real-world conditions. This stage would move beyond laboratory or greenhouse settings into operational environments where water conditions, weather, microbial communities, and management constraints can influence outcomes. Field trials would be designed to measure whether S. villarsiae can meaningfully suppress N. peltata infestations, how quickly it acts, how long effects persist, and whether application methods are practical for managers. It would also provide opportunities to monitor for non-target effects in more complex ecosystems and to refine best practices for use, if the agent continues to look promising.

Administratively, the opportunity is categorized as discretionary funding within the Science and Technology and other Research and Development activity area and is associated with CFDA number 12.630. Eligibility is listed broadly as "Others" with additional clarification referenced in the full announcement, which commonly indicates that universities, non-profits, private entities, or other qualified organizations may be able to apply depending on the specific restrictions and requirements described in the eligibility section. Overall, the opportunity is structured as a staged evaluation pipeline: first establish reliable culturing, then demonstrate safety through host-range testing, then quantify effectiveness across multiple target populations, then decide whether the agent is viable and prepare for regulatory progression, and finally, if pursued, validate performance through field demonstrations and trials.

• The Department of Defense, Dept. of the Army -- Corps of Engineers in the science and technology and other research and development sector is offering a public funding opportunity titled "Development of Septoria villarsiae for biological control of Nymphoides peltata" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.630.
• This funding opportunity was created on Dec 09, 2020.
• Applicants must submit their applications by Feb 08, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $20,000.00 in funding.
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for W81EWF 21 SOI 0005

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: